Sudden infant death syndrome and abnormal metabolism of thiamin

Medical Hypotheses

Volumn 85, Issue 6, 2015, Pages 922-926

  Lonsdale, Derrick ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCARBOXYLASE; FURSULTIAMINE; MAGNESIUM; THIAMINE; THIAMINE DERIVATIVE; THIAMINE TRIPHOSPHATE; TRANSKETOLASE; ENOYL COENZYME A HYDRATASE; GLUCOSE; HACL1 PROTEIN, HUMAN;

ALLELE; ARTICLE; BACTERIUM IDENTIFICATION; BERIBERI; CAROTID BODY; CLOSTRIDIUM BOTULINUM; DISEASE ASSOCIATION; DRUG MECHANISM; DYSAUTONOMIA; EVOKED BRAIN STEM AUDITORY RESPONSE; GENETIC RISK; GENOTYPE; HEART MUSCLE CONDUCTION DISTURBANCE; HUMAN; HYPOXIA; MAGNESIUM DEFICIENCY; MATERNAL NUTRITION; METABOLIC DISORDER; NIGHTMARE; NONHUMAN; POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME; PSEUDOHYPOXIA; QT PROLONGATION; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; STRESS; SUDDEN INFANT DEATH SYNDROME; VACCINATION; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; ADOLESCENT; AUDITORY EVOKED POTENTIAL; BLOOD; BRAIN STEM; CELL MEMBRANE; GENOMICS; INFANT; MENTAL STRESS; METABOLISM; PATHOPHYSIOLOGY; THIAMINE DEFICIENCY;

ADOLESCENT; BRAIN STEM; CELL MEMBRANE; ENOYL-COA HYDRATASE; EVOKED POTENTIALS, AUDITORY; GENOMICS; GLUCOSE; HUMANS; HYPOXIA; INFANT; POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME; PRIMARY DYSAUTONOMIAS; STRESS, PSYCHOLOGICAL; SUDDEN INFANT DEATH; THIAMINE; THIAMINE DEFICIENCY; THIAMINE PYROPHOSPHATE; VACCINATION;

EID: 85015961309     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2015.09.009     Document Type: Article

References (69)

1. Lucchini L., Signorini M.G., Fifer W.P., Sahni R. Multi-parametric heart rate analysis in premature babies exposed to sudden infant death syndrome. Conf Proc IEEE Eng Med Biol Soc 2014, 2014:6389-6392. 10.1109/EMBC.2014.6945090.
2. Lavezzi A.M., Corna M.F., Matturri L. Disruption of the brain-derived neurotrophic factor (BDNF) immunoreactivity in the human Kolliker-Fuse nucleus in victims was of unexplained fetal and infant death. Front Hum Neurosci 2014 Sep 4, 8:648. [ecollection]. 10.3389/fnhum.2014.00648.
3. Scadding G.K., Brock C., Chouiali F., Hamid Q. Laryngeal inflammation in the sudden-infant-death syndrome. Curr Pediatr Rev 2014, 10(4):309-313.
4. Lavezzi A.M., Pusiol T., Matturri L. Cytoarchitectural and functional abnormalities of the inferior colliculus in sudden unexplained perinatal death. Medicine (Baltimore) 2015, 94(6):487.
5. Hutchison B.L., Thompson J.M., Mitchell E.A. Infant care practices related to sudden unexpected death in infancy: a 2013 survey. N Z Med J 2015, 128(1408):15-22.
6. Fleming PJ, Blair PS, Pease A. Sudden unexpected death in infancy: aetiology, pathophysiology, epidemiology and prevention in 2015. Arch Dis Child 2015 Feb 19. pii: archdischild-2014-306424. http://dx.doi.org/10.1136/archdischild-2014-306424 [Epub ahead of print]. http://dx.doi.org/10.1136/archdischild-2014-306424.
7. Wennergren G. New guidelines for reducing the risk of sudden infant death. "Triple risk model". Lakartidningen 2014, 111(38):1564-1565. [Article in Swedish].
8. Fehily L. Human milk intoxication due to B1 avitaminosis. Brit Med J 1944, 2:590-592.
9. Read D.J. The etiology of the sudden infant death syndrome: current ideas on breathing and sleep and possible links to deranged thiamine neurochemistry. Aust N Z J Med 1978, 8(3):322-336.
10. Jeffrey H.E., McCleary B.V., Hensley W.J., Read D.J. Thiamin deficiency-a neglected problem of infants and mothers-possible relationship to sudden infant death syndrome. Aust N Z J Obstet Gynaecol 1985, 25(3):198-202.
11. Jeffery H.E., Rahilly P., Read D.J. Multiple causes of asphyxia in infants at high risk for sudden infant death. Arch Dis Child 1983, 58(2):92-100.
12. Peterson D.R., Labbe R.F., van Belle G., Chinn N.M. Erythrocyte transketolase activity and sudden infant death. Am J Clin Nutr 1981, 34(1):65-67.
13. Davis R.E., Icke G.C., Nilton J.M. High serum thiamin and the sudden infant death syndrome. Clin Chim Acta 1982, 123(3):321-328.
14. Hilton J.M. Pathology of the sudden infant death syndrome in Western Australia: a review of 50 cases. Aust Pediatr J 1986, 22(Suppl. 1):5-6.
15. Phua K.H., Goh L.G., Koh K., et al. Thiamine deficiency and sudden deaths: lessons from the past. Lancet 1990, 335(8703):1471-1472.
16. Luxemburger C., White N.J., ter Kuile F., et al. Beri-beri: the major cause of infant mortality in Karen refugees. Trans R Soc Trop Med Hyg 2003, 97(2):251-255.
17. Lonsdale D. Thiamine and magnesium deficiencies: keys to disease. Med Hypotheses 2015, 84(2):123-134.
18. Johnson S. The multifaceted and widespread pathology of magnesium deficiency. Med Hypotheses 2001, 56(2):163-170.
19. Caddell J.L. Hypothesis: new concepts concerning the pathophysiology of the sudden infant death syndrome due to magnesium deficiency shock. Magnes Res 1992, 5(3):165-172.
20. Caddell J.L. Hypothesis: possible links between the respiratory distress syndrome of the premature neonate, the sudden infant death syndrome, and magnesium deficiency shock. Magnes Res 1993, 6(1):25-32.
21. Caddell J.L. A review of the status of magnesium and related minerals in the sudden-infant-death syndrome (SIDS). Magnes Res 2000, 13(3):205-216.
22. Caddell J.L. Magnesium deficiency promotes muscle weakness, contributing to the risk of sudden infant death (SIDS) in infants sleeping prone. Magnes Res 2001, 14(1-2):39-50.
23. Caddell J.L. The apparent impact of gestational magnesium (Mg) deficiency on the sudden infant death syndrome (SIDS). Magnes Res 2001, 14(4):291-303.
24. Durlach J., Pages N., Bac P., Bara M., Guiet-Bara A. Magnesium deficit and sudden infant death syndrome (SIDS): SIDS due to magnesium deficiency and SIDS due to various forms of magnesium depletion: possible importance of the chronopathological form. Magnes Res 2002, 15(3-4):269-278.
25. Durlach J. New data on the importance of gestational Mg deficiency. J Am Coll Nutr 2004, 23(6):694S-700S.
26. Durlach J., Pages N., Bac P., Bara M., Guiet-Bara A. Importance of magnesium depletion with hypofunction of the biological clock in the pathophysiology of headaches with photophobia, sudden infant death and some clinical forms of multiple sclerosis. Magnes Res 2004, 17(4):314-326.
27. Nasulewicz A., Zimowska W., Bayle D., Dzimira S., Madej J., Rayssiguier Y., et al. Changes in gene expression in the lungs of Mg-deficient mice are related to an inflammatory process. Magnes Res 2004, 17(4):259-263.
28. Nodar R.H., Lonsdale D., Orlowski J.P. Abnormal brain stem potentials in infants with threatened sudden infant death syndrome. Otolaryngol Head Neck Surg (1979) 1980, 88(5):619-621.
29. Orlowski J.P., Lonsdale D., Nodar R.H., Williams G.W. Brainstem dysfunction in the infant apnea syndrome. Clin Electroencephalogr 1982, 13(4):226-232.
30. Pettigrew A.G., Rahilly P.M. Brainstem auditory evoked responses in infants at risk of sudden infant death 1985, 11(2):99-111.
31. Lonsdale D. Sudden infant death syndrome requires genetic predisposition, some form of stress and marginal malnutrition. Med Hypotheses 2001, 57(3):382-386.
32. Brown G. Defects of thiamin transport and metabolism. J Inherit Metab Dis 2014, 57(4):577-585.
33. Bravata V., Minafra L., Callari G., Gelfi C., Edoardo Grimaldi L.M. Analysis of thiamin transporter genes in sporadic beriberi. Nutrition 2014, 30(4):485-488.
34. Laer K., Vennemann M., Rothamel T., Klintschar M. Association between polymorphisms in the P2RY1 and the SSTR2 genes and sudden infant death syndrome. Int J Legal Med 2013, 127(6):1087-1091.
35. Bejanni C., Machaalani R., Waters K.A. The dorsal motor nucleus of the vagus (DMNV) in sudden infant death syndrome. Respir Physiol Neurobiol 2013, 185(2):203-210.
36. Garcia A.J., Koschnitzky J.E., Ramirez J.M. The physiological determinants of sudden infant death syndrome. Respir Physiol Neurobiol 2013, 189(2):288-300.
37. Richardson B.A. Sudden infant death syndrome. J Forensic Sci Soc 1994, 34(3):199-204.
38. Ringe H., Schuelke M., Weber S., Dorner B.G., Kirchner S., Dorner M.B. Infant botulism: is there an association with thiamine deficiency?. Pediatrics 2014, 134(5):e1436-1440.
39. Nevas M., Lindstrom M., Virtanen A., et al. Botulism acquired from household dust presenting as sudden infant death syndrome. J Clin Microbiol 2005, 43(1):511-513.
40. Bartram U., Singer D. Infant botulism and sudden infant death syndrome. Klin Pediatr 2004, 216(1):26-30. [Article in German].
41. Bohnel H., Behrens S., Loch P., Lube K., Gessler F. Is there a link between infant botulism and sudden infant death? Bacteriological results obtained in central Germany. Eur J Pediatr 2001, 10:623-628.
42. Bettendorff L., Wins P. Thiamin diphosphate in biological chemistry, new aspects of thiamin metabolism, especially triphosphate derivatives acting other than as cofactors. FEBS J 2009, 276(11):2917-2925.
43. Bettendorff L., Lakaye B., Kohn G., Wins P. Thiamine triphosphate: a ubiquitous molecule in search of a physiological role. Metab Brain Dis 2014, 29(4):1069-1082.
44. Manzetti S., Zhang J., van der Spoel D. Thiamin function, metabolism, uptake, and transport. Biochemistry 2014, 53(5):821-835.
45. Casteels M., Sniekers M., Fraccascia P., Mannaerts G.P., Van Veldhoven The role of 2-hydroxyacyl CoA lyase, a thiamin pyrophosphate-dependent enzyme, in the peroxisomal metabolism of 3-methyl-branched fatty acids and 2-hydroxy straight-chain fatty acids. Biochem Soc Trans 2007, 35(Pt 5):876-880.
46. Fraccascia P., Casteels M., De Schryver E., Van Veldhoven P.P. Role of thiamin pyrophosphate in oligomerisation, functioning and import of peroxisomal 2-hydroxy acyl-Co A lyase. Biochim Biophys Acta 2011, 1814(10):1226-1233.
47. Fraccascia P., Casteels M., De Schryver E., Van Veldhoven P.P. Presence of thiamin pyrophosphate in mammalian peroxisomes. BMC Biochem 2007, 8:10.
48. Gangolf M., Czerniecki J., Radermecker M., Detry O., Nisolle M., Jouan C., et al. Thiamin status in humans and content of phosphorylated thiamine derivatives in biopsies and cultured cells. PLoS One 2010, 5(10):e13616.
49. Lonsdale D. Hypothesis and case reports: possible thiamin deficiency. J Am Coll Nutr 1990, 9(1):13-17.
50. Barker JN, Jordan F. Phrenic thiamin and neuropathy in sudden infant deaths. In: Sable HZ, Gubler CJ, editors. Thiamin: twenty years of progress. Ann N Y Acad Sci 1982;378:449-52.
51. Porzionato A., Macchi V., Stecco C., De Caro R. The carotid body in sudden infant death syndrome. Respir Physiol Neurobiol 2013, 185(1):194-201.
52. Nussinovitch U., Katz U., Nussinovitch M., Nussinovitch N. Late ventricular potentials and QT dispersion in familial dysautonomia. Pediatr Cardiol 2009, 30(6):747-751.
53. Groswasser Franco P., Asch J., Scaillet S., et al. QT interval prolongation in future SIDS victims: a polysomnographic study. Sleep 2008, 51(12):1691-1699.
54. Gronli J.O., Santucci B.A., Leurgans S.E., Berry-Kravis E.M., Weese-Mayer D.E. Congenital central hypoventilation syndrome: PHOX2B genotype determines risk for sudden death. Pediatr Pulmonol 2008, 43(1):77-86.
55. Kim J.B., Hong S., Park J.W., Cho D.H., Park K.J., Kim B.J. Utility of corrected QT interval in orthostatic intolerance. PLoS One 2014, 9(9):e106417.
56. Munger R.G., Prineas R.J., Crow R.S., et al. Prolonged QT interval and risk of sudden death in South-East Asian men. Lancet 1991, 338(8762):280-281.
57. Melles R.B., Katz B. Night terrors and sudden unexplained nocturnal death. Med Hypotheses 1988, 26(2):149-154.
58. Parekh B. The mechanism of dead-in-bed syndrome and other sudden unexplained nocturnal deaths. Cur Diabetes Rev 2009, 5(4):210-215.
59. Pacal L., Kurikova K., Kankova K. Evidence for altered thiamine metabolism in diabetes: is there a potential to oppose gluco- and lipotoxicity by rational supplementation?. World J Diabetes 2014, 5(3):288-295.
60. Zapata Vazquez R.E., Coetzee A., Harlock E., Simmerson M., Cohen M.C. Measurement of nucleated red blood cells in the peripheral blood as a marker of hypoxia in sudden unexpected death in infancy. J Clin Pathol 2015, 68(9):718-722. 10.1136/jclinpath-2015-202909.
61. Vortmeyer A.O., Hagel C., Laas R. Hypoxia-ischemia and thiamine deficiency. Clin Neuropathol 1993, 12(4):184-190.
62. Sweet R.L., Zastre J.A. HIF1-alpha-mediated gene expression induced by vitamin B1 deficiency. Int J Vitamin Nutr Res 2013, 83(3):188-197.
63. Lonsdale D. A review of the biochemistry, metabolism and clinical benefits of thiamin(e) and its derivatives. Evid Based Complement Alternat Med 2006, 3(1):49-59.
64. Lonsdale D. Thiamine tetrahydrofurfuryl disulfide: a little known therapeutic agent. Med Sci Monit 2004, 10(9):RA199-203.
65. Lonsdale D., Nodar R.H., Orlowski J.P. Brainstem dysfunction in infants responsive to thiamine disulfide: preliminary studies in four patients. Clin Electroencephalogr 1982, 13(2):82-88.
66. Lonsdale D., Shamberger R.J., Audhya T. Treatment of autistic spectrum children with thiamin tetrahydrofurfuryl disulfide: a pilot study. Neuro Endocrinol Lett 2002, 23(4):303-308.
67. Nozaki S., Mizuma H., Tanaka M., Jin G., Tahara T., Mizuno K., et al. Thiamine tetrahydrofurfuryl disulfide improves energy metabolism and physical performance during physical-fatigue loading in rats. Nutr Res 2009, 29(12):867-872.
68. Hills J.I., Golub M.S., Bettendorff L., Keen C.L. The effect of thiamine tetrahydrofurfuryl disulfide on behavior of juvenile DBA/2J mice. Neurotoxicol Teratol 2012, 34(2):242-252.
69. Peters R.A. The biochemical lesion in vitamin B1 deficiency. Lancet 1936, 1:1162-1165.